AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)
$15.82 -0.14 (-0.8772%)
Analysed AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) News Sources
United rises on IPF results; Biogen scores positive lupus data and an approval
30-03-2026
biopharmadive.com
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
30-03-2026
yahoo.com
Does Aurinia’s Tang‑Led Leadership Overhaul Reshape the Bull Case for Aurinia Pharmaceuticals (AUPH)?
29-03-2026
yahoo.com
Mutiny At Aurinia Pharmaceuticals? Biotech Rallies On C-Suite Shake-Up
23-03-2026
yahoo.com
MKT Capital Applauds Aurinia Pharmaceuticals’ Management Transition
23-03-2026
yahoo.com
Aurinia Announces Management Transition
23-03-2026
yahoo.com
Evommune Stock Sees RS Rating Rise To 91
18-03-2026
yahoo.com
Is Aurinia Pharmaceuticals (AUPH) Pricing Reflect Long Term Value After 71% One Year Gain
15-03-2026
yahoo.com
W.R. Berkley, Ziff Davis, and More Stocks See Action From Activist Investors
14-03-2026
yahoo.com
KalVista Pharmaceuticals Stock Sees RS Rating Jump To 86
11-03-2026
yahoo.com
What is the current price of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The current price of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is $15.82.
AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) since the previous trading day is $-0.14.
AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) since the previous trading day is -0.8772%.
What is the most recent average sentiment score for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The most recent average sentiment score for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The most recent sentiment for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is .
SEC-8K** Filing Available For AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.